Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Fangchen Peng"'
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
BackgroundThis study aimed to explore the risk factors for failed treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia (CRAB-VAP) with tigecycline and to establish a predictive model to predict the incidence of fa
Externí odkaz:
https://doaj.org/article/7e4e2a74d10c4386a76dc996b2db8859
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Tigecycline and cefoperazone/sulbactam can cause coagulation disorders; tigecycline may also lead to hypofibrinogenemia, raising safety concerns. This study aimed to investigate whether tigecycline plus cefoperazone/sulbactam increases th
Externí odkaz:
https://doaj.org/article/37f6453b6bef4fb4bdb4286f24e20227
Publikováno v:
Frontiers in Pharmacology; 2024, p1-8, 8p
Autor:
Fangchen Peng, Jinlin Guo, Hongming Ji, Shan Wang, Yuanping Li, Xingang Li, Jiuhong Ma, Yiqi Sun
Publikováno v:
Annals of Pharmacotherapy. 56:888-897
Background Valproic acid (VPA) has been widely used to prevent epileptic seizures after neurosurgery in China. We have found that the incidence of liver injury (LI) in patients using VPA after neurosurgery is higher than that in other patients. Objec